RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Amyloid-beta peptide is central to the pathology of Alzheimer's disease, because it is neurotoxic--directly by inducing oxidant stress, and indirectly by activating microglia. A specific cell-surface acceptor site that could focus its effects on target cells has been postulated but not identified. Here we present evidence that the 'receptor for advanced glycation end products' (RAGE) is such a receptor, and that it mediates effects of the peptide on neurons and microglia. Increased expressing of RAGE in Alzheimer's disease brain indicates that it is relevant to the pathogenesis of neuronal dysfunction and death.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Yan et al. reported that Aβ peptides and Aβ oligomers can bind to RAGE receptor and activate glial cells.331”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [331]
In the citing paper
“Given that intracellular A β overload can induce oxidative stress and cell death [ 38-40 ]”
From Restores Aβ Clearance by Overcoming PCSK9–LRP1 Dysregulation and TRIB3‐Mediated Autophagy Blockade in Alzheimer's Disease (2026) · cites this paper as [38]
In the citing paper
“Enhancing A β uptake or efflux alone may increase intracellular A β -handling burden if autophagic degradation remains impaired [ 38-40 ].”
From Restores Aβ Clearance by Overcoming PCSK9–LRP1 Dysregulation and TRIB3‐Mediated Autophagy Blockade in Alzheimer's Disease (2026) · cites this paper as [38]
In the citing paper
“Apolipoprotein E3 (ApoE3), another key component of the lipoprotein‐like nanostructure, acts as an effective anti‐inflammatory molecule.[ 18 ]”
From Multifunctional Nanostructure RAP‐RL Rescues Alzheimer's Cognitive Deficits through Remodeling the Neurovascular Unit (2021) · cites this paper as [18]
In the citing paper
“In addition, a key component of RAP‐RL, ApoE3, has been shown to regulate pericyte‐mediated cerebrovascular integrity and anti‐inflammatory reaction.[ 18 , 19 ]”
From Multifunctional Nanostructure RAP‐RL Rescues Alzheimer's Cognitive Deficits through Remodeling the Neurovascular Unit (2021) · cites this paper as [18]
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268
Hydrogen peroxide mediates amyloid β protein toxicity
Behl, C. (1994) · Cell · doi:10.1016/0092-8674(94)90131-7 · Cited by 2,074
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975
Osborn, L., Hession, C., Tizard, R., Vassallo, C., Luhowskyj, S., Chi-Rosso, G., & Lobb, R. (1989) · Cell · doi:10.1016/0092-8674(89)90775-7 · Cited by 1,689
Neeper, M., Schmidt, A. M., Brett, J., Yan, S. D., Wang, F., Pan, Y. C., Elliston, K., Stern, D., & Shaw, A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42138-2 · Cited by 1,541
Self-citationNeurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state
Pike, C., Burdick, D., Walencewicz, A., Glabe, C., & Cotman, C. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-04-01676.1993 · Cited by 1,417
Activation of microglial cells by β-amyloid protein and interferon-γ
Meda, L., Cassatella, M. A., Szendrei, G. I., Otvos, L., Baron, P., Villalba, M., Ferrari, D., & Rossi, F. (1995) · Nature · doi:10.1038/374647a0 · Cited by 1,314
Yan, S. D., Schmidt, A. M., Anderson, G. M., Zhang, J., Brett, J., Zou, Y. S., Pinsky, D., & Stern, D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36966-1 · Cited by 1,306
Self-citationThe Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for Amphoterin
Hori, O., Brett, J., Slattery, T., Cao, R., Zhang, J., Chen, J. X., Nagashima, M., Lundh, E. R., Vijay, S., Nitecki, D., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.43.25752 · Cited by 1,151
Self-citationHensley, K., Carney, J. M., Mattson, M. P., Aksenova, M., Harris, M., Wu, J. F., Floyd, R. A., & Butterfield, D. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3270 · Cited by 1,086
Research works printed but not linked: 4
- Haass, C. & Selkoe, D. Cell 7, 1039–1042 (1994).
- Trojanowski, J. & Lee, V. Am. J. Pathol. 144, 449–453 (1994).
- Gumkowski, F. et al. Blood Vessels 24, 11–18 (1987).
- Brett, J. et al. Am. J. Pathol. 143, 1699–1712 (1993).
Cited by
Items 601–700 of 1,027
Picone, P., Carrotta, R., Montana, G., Nobile, M. R., Biagio, P. L. S., & Carlo, M. D. (2009) · Biophysical Journal · doi:10.1016/j.bpj.2008.11.056 · Cited by 102
The effects of cardiovascular risk factors on cognitive compromise
Beeri, M. S., Ravona-Springer, R., Silverman, J. M., & Haroutunian, V. (2009) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2009.11.2/msbeeri · Cited by 99
Role of amyloid peptides in vascular dysfunction and platelet dysregulation in Alzheimer’s disease
Canobbio, I., Abubaker, A. A., Visconte, C., Torti, M., & Pula, G. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00065 · Cited by 112
“RAGE facilitates soluble Aβ peptides transport across BBB and across the cortical neurons intracellular space (Yan et al., 1996; Sasaki et al., 2001; Takuma et al., 2009).”
BackgroundBlockage of CR1 prevents activation of rodent microglia
Crehan, H., Hardy, J., & Pocock, J. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.02.003 · Cited by 98
Soluble RAGEs — Prospects for treating & tracking metabolic and inflammatory disease
Schmidt, A. M. (2015) · Vascular Pharmacology · doi:10.1016/j.vph.2015.06.011 · Cited by 98
Self-citationGrzanna, R., Phan, P., Polotsky, A., Lindmark, L., & Frondoza, C. G. (2004) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2004.10.1009 · Cited by 98
“…studies have provided support for this hypothesis by demonstrating that the fibrillar form of A (cid:1) can serve as an inflammatory stimulus for microglial lineage cells and that activated microglial cells kill neurons in coculture (Combs et al., 2001; Giulian et al., 1996; Yan et al., 1996).”
He, P., Ouyang, X.-P., Zhou, S., Yin, W., Tang, C., Laudon, M., & Tian, S. (2013) · Hormones and Behavior · doi:10.1016/j.yhbeh.2013.04.009 · Cited by 106
Serlin, Y., Levy, J., & Shalev, H. (2011) · Cardiovascular Psychiatry and Neurology · doi:10.1155/2011/609202 · Cited by 99
“Increased expression of RAGE in Alzheimer’s disease brain, indicates its relevancy in the pathogenesis of neuronal dysfunction and death [87].”
BackgroundDiabetes, leukoencephalopathy and rage
Toth, C. C., Schmidt, A. M., Tuor, U. I., Francis, G. J., Foniok, T., Brussee, V., Kaur, J., Yan, S. F., Martinez, J. A., Barber, P. A., et al. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.03.015 · Cited by 104
Self-citationOyama, R., Yamamoto, H., & Titani, K. (2000) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(00)00057-1 · Cited by 104
Protection Against Oxidative Stress‐induced Neuronal Cell Death‐A Novel Role for RU486
Behl, C., Trapp, T., Skutella, T., & Holsboer, F. (1997) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1997.tb01442.x · Cited by 98
Advances and Challenges in the Prevention and Treatment of Alzheimer's Disease
Brinton, R. D., & Yamazaki, R. S. (1998) · Pharmaceutical Research · doi:10.1023/a:1011963929012 · Cited by 99
The α5β1 Integrin Mediates Elimination of Amyloid-β Peptide and Protects Against Apoptosis
Matter, M. L., Zhang, Z., Nordstedt, C., & Ruoslahti, E. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.4.1019 · Cited by 98
“The receptor for advanced glycation end products binds both the soluble and fibrillar forms of A b , and may mediate some of the cytotoxic effects of fibrillar A b (Yan et al., 1996).”
BackgroundCellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease
Mroczko, B., Groblewska, M., Litman-Zawadzka, A., Kornhuber, J., & Lewczuk, P. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071884 · Cited by 97
RAGE: a new frontier in chronic airways disease
Sukkar, M. B., Ullah, M. A., Gan, W. J., Wark, P. A. B., Chung, K. F., Hughes, J. M., Armour, C. L., & Phipps, S. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01984.x · Cited by 108
“, 2007), amyloid b peptide (Yan et al., 1996), complement 3a (C3a), heat shock protein 70 (HSP70), the matricellular injury-related glycoprotein SPARC (secreted protein acidic and rich in cysteine) (Ruan et al.”
BackgroundSignal Transduction Cascades Associated with Oxidative Stress in Alzheimer's Disease
Petersen, R. B., Nunomura, A., Lee, H.-G., Casadesus, G., Perry, G., Smith, M. A., & Zhu, X. (2007) · Journal of Alzheimer's Disease · doi:10.3233/jad-2007-11202 · Cited by 97
The amyloid‐β peptide and its role in Alzheimer's disease
Clippingdale, A. B., Wade, J. D., & Barrow, C. J. (2001) · Journal of Peptide Science · doi:10.1002/psc.324 · Cited by 97
Pichiule, P., Chavez, J. C., Schmidt, A. M., & Vannucci, S. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706407200 · Cited by 108
Self-citationHarkany, T., Hortobágyi, T., Sasvári, M., Kónya, C., Penke, B., Luiten, P. G. M., & Nyakas, C. J. (1999) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(99)00058-5 · Cited by 105
Binding and uptake of Aβ1‐42 by primary human astrocytes in vitro
Nielsen, H. M., Veerhuis, R., Holmqvist, B., & Janciauskiene, S. (2009) · Glia · doi:10.1002/glia.20822 · Cited by 96
Pinocembrin improves cognition and protects the neurovascular unit in Alzheimer related deficits
Liu, R., Li, J.-Z., Song, J., Zhou, D., Huang, C., Bai, X., Xie, T., Zhang, X., Li, Y., Wu, C., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.12.031 · Cited by 100
“, 2003; Zlokovic, 2005) and neuronal dysfunction (Takuma et al., 2009; Walsh et al., 2002; Yan et al., 1996), causes oxidative stress, and mediates chronic inflammatory processes, which are involved in the neurovascular unit (NVU) pathology.”
Derk, J., MacLean, M., Juranek, J., & Schmidt, A. M. (2018) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000421 · Cited by 96
Self-citationAGE–RAGE stress: a changing landscape in pathology and treatment of Alzheimer’s disease
Prasad, K. (2019) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-019-03553-4 · Cited by 101
Advanced glycation end products and diabetic retinopathy
Milne, R. W., & Brownstein, S. (2011) · Amino Acids · doi:10.1007/s00726-011-1071-3 · Cited by 105
“…a member of the immunoglobulin superfamily and binds a number of ligands in addition to AGEs including b-amyloid peptide and other b–sheet fibrils (Yan et al. 1996), S100/calgranulins (Hofmann et al. 1999) , amphoterin [also called high-mobility group box 1 (HMBG1)] (Hori et al. 1995 ) and…”
BackgroundDisruption of blood-brain barrier in Alzheimer disease pathogenesis
Kook, S.-Y., Seok Hong, H., Moon, M., & Mook-Jung, I. (2013) · Tissue Barriers · doi:10.4161/tisb.23993 · Cited by 95
Diverse activation of microglia by chemokine (C-C motif) ligand 2 overexpression in brain
Selenica, M.-L. B., Alvarez, J. A., Nash, K. R., Lee, D. C., Cao, C., Lin, X., Reid, P., Mouton, P. R., Morgan, D., & Gordon, M. N. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-86 · Cited by 95
“receptor that has been implicated in many chronic inflammatory diseases, including AD [83,84].”
BackgroundShrivastava, A. N., Aperia, A. C., Melki, R., & Triller, A. (2017) · Neuron · doi:10.1016/j.neuron.2017.05.026 · Cited by 98
Businaro, R., Leone, S., Fabrizi, C., Sorci, G., Donato, R., Lauro, G. M., & Fumagalli, L. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20785 · Cited by 95
“Previous work has shown that RAGE binds Ab peptide (Yan et al., 1996), thereby mediating transcytosis of circulating Ab peptide into the brain, whereas LRP clears brain Ab peptide into the blood (Deane et al., 2004).”
BackgroundTakeuchi, M., Takino, J.-I., & Yamagishi, S.-I. (2010) · Current Drug Targets · doi:10.2174/1389450111009011468 · Cited by 95
“Several types of AGEs binding proteins and/or receptors for AGEs such as RAGE [32-36]; oligosaccharyl transferase-48 (AGE-R1) [37]; galectin-3 (AGE-R3) [38]; CD36 [39]; macrophage scavenger receptors types 1 and 2 (MSR-1 & -2) [40]; and fasciclin EGF-like, laminintype EGF-like, and link domain-containing scavenger rec…”
Receptors for chemotactic formyl peptides as pharmacological targets
Le, Y., Yang, Y., Cui, Y., Yazawa, H., Gong, W., Qiu, C., & Wang, J. M. (2002) · International Immunopharmacology · doi:10.1016/s1567-5769(01)00150-3 · Cited by 106
Liu, L., Wan, W., Xia, S., Kalionis, B., & Li, Y. (2014) · Neurochemistry International · doi:10.1016/j.neuint.2014.05.004 · Cited by 107
S100B Promotes Glioma Growth through Chemoattraction of Myeloid-Derived Macrophages
Wang, H., Zhang, L., Zhang, I. Y., Chen, X., Fonseca, A. D., Wu, S., Ren, H., Badie, S., Sadeghi, S., Ouyang, M., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3725 · Cited by 97
Self-citationIs RAGE Still A Therapeutic Target For Alzheimer’s Disease?
Deane, R. J. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.51 · Cited by 94
Touré, F., Fritz, G., Li, Q., Rai, V., Daffu, G., Zou, Y. S., Rosario, R., Ramasamy, R., Alberts, A. S., Yan, S. F., et al. (2012) · Circulation Research · doi:10.1161/circresaha.111.262519 · Cited by 94
Self-citationABC Transporters Are Key Players in Alzheimer’s Disease
Pereira, C. D., Martins, F., Wiltfang, J., da Cruz e Silva, O. A. B., & Rebelo, S. (2017) · Journal of Alzheimer's Disease · doi:10.3233/jad-170639 · Cited by 93
Pathological Implications of Receptor for Advanced Glycation End-Product (AGER) Gene Polymorphism
Dancer, M. S., Jabaudon, M., Creveaux, I., Belville, C., Blondonnet, R., Gross, C., Constantin, J., Blanchon, L., & Sapin, V. (2019) · Disease Markers · doi:10.1155/2019/2067353 · Cited by 98
“Recently, sRAGE was demonstrated as a new biomarker for lung cancer and RAGE could be a potential therapeutic target in Alzheimer’s disease [23, 24].”
BackgroundThe Role of Neurovascular System in Neurodegenerative Diseases
Ahmad, A., Patel, V., Xiao, J., & Khan, M. M. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02023-z · Cited by 105
Calcium signaling in microglial cells
Möller, T. (2002) · Glia · doi:10.1002/glia.10152 · Cited by 93
“Several receptors have been postulated to transduce the effects of A , including the scavenger receptors (SRs) (El Khoury et al., 1996; Paresce et al., 1996), the receptor for advanced glycated end products (RAGE) (Yan et al., 1996) and the serpin-enzyme complex receptor (Boland et al., 1996).”
BackgroundLv, C., Wang, L., Liu, X., Yan, S., Yan, S. S., Wang, Y., & Zhang, W. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.09.019 · Cited by 95
“The generation and secretion of proinflammatory mediators that contribute to neuronal, synaptic and cognitive dysfunction in AD (Yan et al., 1996; Origlia et al., 2009, 2010; Fang et al., 2010) may interact at multiple levels with neurodegenerative mechanisms.”
BackgroundSelf-citationKim, S.-W., Lim, C., Kim, J., Shin, J., Lee, S., Lee, M., & Lee, J.-K. (2010) · Neurotoxicity Research · doi:10.1007/s12640-010-9231-x · Cited by 98
“In the brain, RAGE is expressed in neurons, glia, and endothelial cells ( Yan et al. 1996; Qiu et al. 2008).”
BackgroundThe S100B/RAGE Axis in Alzheimer's Disease
Leclerc, E., Sturchler, E., & Vetter, S. W. (2010) · Cardiovascular Psychiatry and Neurology · doi:10.1155/2010/539581 · Cited by 93
“RAGE is up-regulated in the brain of Azheimer’s disease and triggers the generation of proinflammatory cytokines at the blood brain barrier [13, 27].”
BackgroundInfluentialLee, G., Pollard, H. B., & Arispe, N. J. (2002) · Peptides · doi:10.1016/s0196-9781(02)00060-8 · Cited by 104
Askarova, S., Yang, X., Sheng, W., Sun, G. Y., & Lee, J. C.-M. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.09.038 · Cited by 92
“Inhibition studies have indicated that anti-RAGE IgG significantly suppressed oxidative stress induced by Aβ both in vascular and neuronal cell (Yan et al., 1996); however, the relationship between AβRAGE interactions and NADPH oxidase has yet to be elucidated.”
Molecular Characteristics of RAGE and Advances in Small-Molecule Inhibitors
Kim, H. J., Jeong, M. S., & Jang, S. B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136904 · Cited by 110
“RAGE also binds amyloid-β peptides (Aβ40 and Aβ42), which form aggregates in the brain and promote neurodegeneration [5] and may also act as mediators of disease progression in AD by interacting with Aβ and transporting it across the blood-brain barrier (BBB).”
BackgroundRole of high mobility group protein-1 (HMG1) in amyloid-β homeostasis
Takata, K., Kitamura, Y., Kakimura, J., Shibagaki, K., Tsuchiya, D., Taniguchi, T., Smith, M. A., Perry, G. L., & Shimohama, S. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00024-x · Cited by 101
The Inflammatory Response in Alzheimer's Disease
Rogers, J. (2008) · Journal of Periodontology · doi:10.1902/jop.2008.080171 · Cited by 92
Cerebrovascular Effects of Amyloid-ß Peptides: Mechanisms and Implications for Alzheimer's Dementia
Iadecola, C. (2003) · Cellular and Molecular Neurobiology · doi:10.1023/a:1025092617651 · Cited by 97
“…in the brain of AD patients (Good et al., 1996; Smith et al., 1997), Aß is well known to produce ROS (Behl et al., 1994; Hensley et al., 1994), an effect that in some models is mediated by Aß-induced activation of the receptor for advanced glycosylation end products (RAGE) (Yan et al., 1996).”
Iribarren, P., Chen, K., Hu, J., Gong, W., Cho, E. H., Lockert, S., Uranchimeg, B., & Wang, J. M. (2005) · The FASEB Journal · doi:10.1096/fj.05-4578fje · Cited by 92
Lee, L., Sakurai, M., Matsuzaki, S., Arancio, O., & Fraser, P. (2013) · NeuroMolecular Medicine · doi:10.1007/s12017-013-8257-7 · Cited by 91
“The subsequent neurodegenerative cell death features prominently in AD and accounts for the clinical symptoms of cognitive decline, dementia, and behavioral changes (mGluR5) (Renner et al. 2010), the receptor for advanced glycation end products (RAGE) (Yan et al. 1996; Sturchler et al. 2008), the a7 nicotinic acetylch…”
BackgroundMicroglial signalling cascades in neurodegenerative disease
Pocock, J. M., & Liddle, A. C. (2001) · Progress in brain research · doi:10.1016/s0079-6123(01)32103-9 · Cited by 103
Pappolla, M. A., Simovich, M. J., Bryant‐Thomas, T., Chyan, Y., Poeggeler, B., Dubocovich, M., Bick, R., Perry, G., Cruz‐Sanchez, F., & Smith, M. A. (2002) · Journal of Pineal Research · doi:10.1034/j.1600-079x.2002.1o838.x · Cited by 91
Van Uden, E., Mallory, M., Veinbergs, I., Alford, M., Rockenstein, E., & Masliah, E. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-21-09298.2002 · Cited by 91
“Other receptors involved in A clearance include the receptor for advanced glycation end products (RAGE), scavenger receptor type A (SR-A) (Paresce et al., 1996; Yan et al., 1996; El Khoury et al., 1998), and the G-protein-coupled receptor formyl peptide receptor like-1 (FPRL1) (Yazawa et al., 2001).”
BackgroundTomiyama, T., Kaneko, H., Kataoka, K.-I., Asano, S., & Endo, N. (1997) · Biochemical Journal · doi:10.1042/bj3220859 · Cited by 98
Blood–Brain Barrier and Neurodegenerative Diseases—Modeling with iPSC-Derived Brain Cells
Wu, Y.-C., Sonninen, T.-M., Peltonen, S., Koistinaho, J., & Lehtonen, Š. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147710 · Cited by 89
Manigrasso, M. B., Rabbani, P. S., Egaña-Gorroño, L., Quadri, N., Frye, L., Zhou, B., Reverdatto, S., Ramirez, L. S., Dansereau, S. J., Pan, J., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abf7084 · Cited by 93
Self-citationLiao, M. Q., Tzeng, Y. J., Chang, L. Y. X., Huang, H. B., Lin, T. H., Chyan, C. L., & Chen, Y. C. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.02.026 · Cited by 90
A β Internalization by Neurons and Glia
Mohamed, A., & Posse de Chaves, E. (2011) · International Journal of Alzheimer’s Disease · doi:10.4061/2011/127984 · Cited by 90
Receptor for advanced glycation end products is detrimental during influenza A virus pneumonia
van Zoelen, M. A. D., van der Sluijs, K. F., Achouiti, A., Florquin, S., Braun-Pater, J. M., Yang, H., Nawroth, P. P., Tracey, K. J., Bierhaus, A., & van der Poll, T. (2009) · Virology · doi:10.1016/j.virol.2009.05.032 · Cited by 90
“, 2000) and β-sheet fibrils (Yan et al., 1996).”
BackgroundSelf-citationRole of Nuclear Factor‐Kappa B (NF‐κB) in Inflammation, Periodontitis, and Atherogenesis
Nichols, T. C., Fischer, T. H., Deliargyris, E., & Baldwin, A. S. (2001) · Annals of Periodontology · doi:10.1902/annals.2001.6.1.20 · Cited by 104
Alzheimer's soluble amyloid β is a normal component of human urine
Ghiso, J., Calero, M., Matsubara, E., Governale, S., Chuba, J., Beavis, R., Wisniewski, T., & Frangione, B. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00400-6 · Cited by 89
Amyloid-β-induced Synapse Damage Is Mediated via Cross-linkage of Cellular Prion Proteins
Bate, C., & Williams, A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.248724 · Cited by 89
Tichauer, J. E., & von Bernhardi, R. (2012) · Journal of Neuroscience Research · doi:10.1002/jnr.23082 · Cited by 89
Walker, D. G., & Lue, L. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20484 · Cited by 89
“Ab subfragment 10–20 activated the respiratory burst in human blood-derived macrophages (Van Muiswinkel et al., 1999), whereas region 25–35 resulted in increased oxygen free radical production by microglia, macrophages, and neutrophils (Yan et al., 1996; Della-Bianca et al., 1999).”
BackgroundClusterin and Alzheimer’s Disease
Calero, M., Rostagno, A. A., Frangione, B., & Ghiso, J. A. (2006) · Springer eBooks · doi:10.1007/0-387-23226-5_14 · Cited by 98
Oxidative stress and neural dysfunction in Down Syndrome
Iannello, R. C., Crack, P. J., de Haan, J. B., & Kola, I. (1999) · Springer eBooks · doi:10.1007/978-3-7091-6380-1_17 · Cited by 93
Molecular basis of Alzheimer's disease
Drouet, B., Pinçon‐Raymond, M., Chambaz, J., & Pillot, T. (2000) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050035 · Cited by 103
Targeting microglia for the treatment of Alzheimer’s disease
McGeer, P. L., & McGeer, E. G. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.988707 · Cited by 88
“[54] concentrated on the receptor for advanced glycation endproducts (RAGE) as an Ab tethering molecule, which could trigger cytotoxic stimuli.”
BackgroundAdjusting the compass: new insights into the role of angiogenesis in Alzheimer’s disease
Jefferies, W. A., Price, K. A., Biron, K. E., Fenninger, F., Pfeifer, C. G., & Dickstein, D. L. (2013) · Alzheimer's Research & Therapy · doi:10.1186/alzrt230 · Cited by 87
“Beyond facilitating the entry of Aβ into the brain, in vitro studies have implicated RAGE in the vascular pathogenesis of AD by mediating apoptosis in the brain and suppression of CBF [31,34].”
Strohmeyer, R., Ramirez, M., Cole, G. J., Mueller, K., & Rogers, J. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00272-2 · Cited by 91
Zhang, D., Hu, X., Qian, L., Chen, S.-H., Zhou, H., Wilson, B., Miller, D. S., & Hong, J.-S. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-3 · Cited by 88
“Loike, Scavenger receptor-mediated adhesion of microglia to betaamyloid fibrils, Nat andand and other receptors such as macrophage colony-stimulating factor receptor (MCSF) [31], formyl peptide receptor-1 receptor (FPR-1) [32], receptor for advanced glycation end products (RAGE) [33], etc have been reported to be the…”
BackgroundBalcz, B., Kirchner, L., Cairns, N. J., Fountoulakis, M., & Lübec, G. (2001) · Springer eBooks · doi:10.1007/978-3-7091-6262-0_15 · Cited by 95
All-D-Enantiomers of β-Amyloid Exhibit Similar Biological Properties to All-L-β-Amyloids
Cribbs, D. H., Pike, C. J., Weinstein, S. L., Velazquez, P., & Cotman, C. W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.11.7431 · Cited by 88
Metalloendopeptidase EC 3.4.24.15 Is Necessary for Alzheimer's Amyloid-β Peptide Degradation
Yamin, R., Malgeri, E. G., Sloane, J. A., McGraw, W. T., & Abraham, C. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.26.18777 · Cited by 88
White, A. R., Zheng, H., Galatis, D., Maher, F., Hesse, L., Multhaup, G., Beyreuther, K., Masters, C. L., & Cappai, R. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-16-06207.1998 · Cited by 88
“This could be because A operates via an A-receptor (Yan et al., 1996, 1997), which results in either localized oxidative stress or activation of a specific cell-signaling pathway or both.”
Grimm, S., Ott, C., Hörlacher, M., Weber, D., Höhn, A., & Grune, T. (2012) · Biochemical Journal · doi:10.1042/bj20120298 · Cited by 87
Alzheimer's Disease: Cerebrovascular Dysfunction, Oxidative stress, and Advanced Clinical Therapies
Marlatt, M. W., Lucassen, P. J., Perry, G. L., Smith, M. A., & Zhu, X. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-15206 · Cited by 97
Szczepanik, A. M., Rampe, D., & Ringheim, G. E. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.t01-1-00240.x · Cited by 87
S100A11, an Dual Mediator for Growth Regulation of Human Keratinocytes
Sakaguchi, M., Sonegawa, H., Murata, H., Kitazoe, M., Futami, J., Kataoka, K., Yamada, H., & Huh, N.-H. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-07-0682 · Cited by 97
“RAGE was first identified as a receptor for glycation end products of proteins (Schmidt et al., 1992), but it was soon found to bind diverse ligands, including amyloid (Yan et al., 1996), HMGB1 (amphoterin) (Hori et al., 1995), and some S100 family members (Donato, 2003; Hofmann et al., 1999).”
BackgroundSignal transduction abnormalities in Alzheimer's disease: evidence of a pathogenic stimuli
McShea, A., Zelasko, D. A., Gerst, J. L., & Smith, M. A. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01135-4 · Cited by 87
Recombinant Advanced Glycation End Product Receptor Pharmacokinetics in Normal and Diabetic Rats
Renard, C., Chappey, O., Wautier, M.-P., Nagashima, M., Lundh, E., Morser, J., Zhao, L., Schmidt, A. M., Scherrmann, J., & Wautier, J. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.1.54 · Cited by 91
“Because RAGE seems to be a receptor not only for AGEs but also for amphoterin (21) and amyloid-b peptide (22), there is an interest in better understanding the pathophysiology of RAGE.”
BackgroundSelf-citationOligomerization and fibril assembly of the amyloid-β protein
Roher, A. E., Baudry, J. Y., Chaney, M. O., Kuo, Y., Stine, W. B., & Emmerling, M. R. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00030-2 · Cited by 106
Self-citationFundamental role of C1q in autoimmunity and inflammation
Son, M., Diamond, B., & Santiago‐Schwarz, F. (2015) · Immunologic Research · doi:10.1007/s12026-015-8705-6 · Cited by 93
“generative disorders by activating the pro-inflammatory Jak-STAT and NF-kB signaling pathways [68, 69].”
BackgroundProtein Folding and Misfolding on Surfaces
Stefani, M. (2008) · International Journal of Molecular Sciences · doi:10.3390/ijms9122515 · Cited by 100
Slowik, A., Merres, J., Elfgen, A., Jansen, S., Mohr, F., Wruck, C. J., Pufe, T., & Brandenburg, L.-O. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-55 · Cited by 85
Zhang, K., Tian, L., Liu, L., Feng, Y., Dong, Y.-B., Li, B., Shang, D.-S., Fang, W.-G., Cao, Y.-P., & Chen, Y.-H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072744 · Cited by 86
Alternative splicing of RAGE: roles in biology and disease
Kalea, A. Z. (2011) · Frontiers in bioscience · doi:10.2741/3884 · Cited by 90
Brody, A. H., & Strittmatter, S. M. (2018) · Advances in Pharmacology · doi:10.1016/bs.apha.2017.09.007 · Cited by 86
“[PubMed: 9410912] Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A, et al. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease.”
BackgroundInfluentialComplement C5a anaphylatoxin fragment causes apoptosis in TGW neuroblastoma cells
Farkas, I., Baranyi, L., Liposits, Z., Yamamoto, T., & Okada, H. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00108-0 · Cited by 86
Cotter, R. L., Burke, W. J., Thomas, V. S., Potter, J. F., Zheng, J., & Gendelman, H. E. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.65.4.416 · Cited by 86
“Interacting with receptors on MP, perhaps the receptor for advanced glycation end-products (RAGE) or the scavenger receptor (SR) [26, 27], the b-amyloid protein may induce a series of intracellular events that alters the threshold for cellular activation.”
BackgroundKastman, E. K., Willette, A. A., Coe, C. L., Bendlin, B. B., Kosmatka, K. J., McLaren, D. G., Xu, G., Canu, E., Field, A. S., Alexander, A. L., et al. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.0835-10.2010 · Cited by 85
“As animals age, the rate of nonenzymatic glycation between proteins and sugars increases, leading to the production of advanced glycation end products (AGEs) and subsequent free radical production (Yan et al., 1996).”
BackgroundCyclophilin D deficiency rescues Aβ-impaired PKA/CREB signaling and alleviates synaptic degeneration
Du, H., Guo, L., Wu, X., Sosunov, A. A., McKhann, G. M., Chen, J. X., & Yan, S. S. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.03.004 · Cited by 85
Self-citationThe early contribution of cerebrovascular factors to the pathogenesis of Alzheimer’s disease
Pimentel‐Coelho, P. M., & Rivest, S. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2012.08126.x · Cited by 85
“RAGE mediates Ab-induced oxidative stress in endothelial cells and neurons, as well as Ab-induced microglial activation (Yan et al., 1996).”
BackgroundGiulia, N., Simona, S., Maria, D., & Simona, R. (2017) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026617666170607114232 · Cited by 85
Kupershmidt, L., Amit, T., Bar-Am, O., Youdim, M. B. H., & Weinreb, O. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4279 · Cited by 85
Yatime, L., & Andersen, G. R. (2013) · FEBS Journal · doi:10.1111/febs.12556 · Cited by 95
Reynolds, P. R., Schmitt, R. E., Kasteler, S. D., Sturrock, A., Sanders, K. A., Bierhaus, A., Nawroth, P. P., Paine, R., & Hoidal, J. R. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0265oc · Cited by 96
Self-citationGiridharan, V. V., Thandavarayan, R. A., Arumugam, S., Mizuno, M., Nawa, H., Suzuki, K., Ko, K. M., Krishnamurthy, P., Watanabe, K., & Konishi, T. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142483 · Cited by 87
Interaction of RAGE with α-synuclein fibrils mediates inflammatory response of microglia
Long, H., Zhang, S., Zeng, S., Tong, Y., Liu, J., Liu, C., & Li, D. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111401 · Cited by 90
Lee, S., Chu, K., Park, J., Jung, K., Jeon, D., Lim, J., Lee, S. K., Kim, M., & Roh, J. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07534.x · Cited by 84
“Clearance of Ab in AD brain partly depends on the action of endothelial transporters, such as RAGE and low density lipoprotein receptor-related protein 1(Shibata et al. 2000; Yan et al. 1996).”
BackgroundInfluentialImproved diabetes control in the elderly delays global cognitive decline
Luchsinger, J. A., Palmas, W., Teresi, J. A., Silver, S., Kong, J., Eimicke, J. P., Weinstock, R. S., & Shea, S. (2011) · The Journal of nutrition, health and aging · doi:10.1007/s12603-011-0057-x · Cited by 84
Metadata
- Authors
- Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., Migheli, A., Nawroth, P., Stern, D., & Schmidt, A. M.
- Affiliations
- Columbia University (US)
- University of Turin (IT)
- Heidelberg University (DE)
- Venue
- Nature
- Published
- 1996-08
- Volume
- 382
- Issue
- 6593
- Pages
- 685-691
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2049167261
- Cited by
- 2,012
- References
- 44
- Citations by year
- 2026: 28 · 2025: 33 · 2024: 44 · 2023: 46 · 2022: 56 · 2021: 48 · 2020: 59 · 2019: 58 · 2018: 65 · 2017: 55 · 2016: 77 · 2015: 75 · 2014: 81 · 2013: 93 · 2012: 100
- FWCI
- 58.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- receptor for advanced glycation end products, RAGE, amyloid-beta, neurotoxicity, Alzheimer's disease, microglial activation, oxidative stress, neuronal cell death, cell surface receptors, neuroinflammation
- MeSH terms
- Receptor for Advanced Glycation End Products, Alzheimer Disease, Animals, Base Sequence, Cattle, Cell Line, Cells, Cultured, Endothelium, Vascular, Humans, Molecular Sequence Data, Neurons, Receptors, Immunologic, Biomarkers, Amyloid beta-Peptides, PC12 Cells, Glycation End Products, Advanced, Microglia, DNA Primers, Oxidative Stress, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.